{"ticker": {"uuid": "675194a9-16c0-4c00-bf0f-7e6cf7c87f10", "symbol": "ICCM", "name": "Icecure Medical", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "This Undervalued Medical-Devices Stock Is Poised for a Rebound", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPN1g2RjVsUTVvTmdXRTdJMTRpVTlOQnZIbm9hTWJDdkRaeVpINjFqbXpDUVFpMVdYMExyR2VQQVNpZ3p0V2F1SVJMelpJZWk1bExvb0dYWnJ4VVJJRURseEVQVVZwNnRZREZiQzlFTHlhSHFadGdXRmpxbXA2XzBMNA?oc=5", "source_name": "Barron's", "published_at": "2026-06-22T15:45:00+00:00", "published_display": "22 Jun 2026 15:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Has IceCure Medical's Stock Price Collapsed", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxQU01wa1MxYlVZeWRHWjE0RFFSQzNXdXFaMkQ5MUNLWmxHVDlfaHNFZnJENnlYRHp1WGtHcDF2TXdpNWtOQ2gyX2EzYVlLQ2pGNzJQc3lzQUR2QlVIV3BkZ0dObjZWWWRkOW95dWdqdjdzbUtTM19ITTQtbl90ZWt5R0pKV3RaVGVXNEE?oc=5", "source_name": "Kavout", "published_at": "2026-06-21T06:37:57+00:00", "published_display": "21 Jun 2026 06:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Medical (ICCM) prices $5.5M private placement with warrant package", "summary": "IceCure Medical (ICCM) has priced a $5.5 million private placement with a single institutional investor, involving the issuance of pre-funded warrants and new Series D and E warrants. The company also announced a 70% increase in its active U.S. commercial ProSense\u00ae install base f", "url": "https://www.stocktitan.net/sec-filings/ICCM/6-k-ice-cure-medical-ltd-current-report-foreign-issuer-b70b1f4d7cc5.html", "source_name": "Stock Titan", "published_at": "2026-06-18T21:11:49", "published_display": "18 Jun 2026 21:11", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Medical gains after ProSense update, $5.5M placement", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxQdHZEY1Z3T1ZtTXpTVGV4emZYMGVRNzRzbExIWEk3eFItemlWbVlUXzJ6cjZINzlXWkw2Zm5LZndVaWNBMVk0aXdGSGt2eEpIUE91ZnFfVlVDaEdBOFpIdWJtS01CNno4T3Q1bDRHMUV5NWh2bmVrYVllbkpvaGNJdTFLNzg4UQ?oc=5", "source_name": "TechStock\u00b2", "published_at": "2026-06-18T12:00:34+00:00", "published_display": "18 Jun 2026 12:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tumour freezing specialist IceCure Medical skyrockets from latest successes", "summary": "IceCure Medical Ltd (NASDAQ: ICCM), a company specializing in cryoablation technology for tumors, has seen its shares soar after announcing a 70% increase in its US commercial install base for its ProSense system and a US$5.5 million private placement. The ProSense system uses li", "url": "https://mugglehead.com/tumour-freezing-specialist-icecure-medical-skyrockets-from-latest-successes/", "source_name": "Mugglehead Investment Magazine", "published_at": "2026-06-18T08:40:07", "published_display": "18 Jun 2026 08:40", "sentiment": "positive", "sentiment_pct": 91, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Reports 70% Growth in Active U.S. Commercial Install Base for Breast Cancer Cryoablation Following FDA Clearance", "summary": "IceCure Medical Ltd. reported a 70% increase in its U.S. active commercial install base for ProSense\u00ae breast cancer cryoablation systems since receiving FDA marketing authorization in October 2025. This growth is attributed to accelerating commercial adoption, expanding physician", "url": "https://www.streetinsider.com/PRNewswire/IceCure+Reports+70%25+Growth+in+Active+U.S.+Commercial+Install+Base+for+Breast+Cancer+Cryoablation+Following+FDA+Clearance/26657255.html", "source_name": "StreetInsider", "published_at": "2026-06-17T20:10:26", "published_display": "17 Jun 2026 20:10", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Medical Shares Jump After Update on Commercial Adoption of Breast Cancer Cryoablation Procedures", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/icecure-medical-shares-jump-commercial-180907961.html", "source_name": "MT Newswires", "published_at": "2026-06-17T18:09:07+00:00", "published_display": "17 Jun 2026 18:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Medical (ICCM) Sees 70% Surge in Cryoablation Install Ba", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPMEtDSlQ2QU9JTHZwNk85c1I4a1A5d1dxaWdtNm0tZW5Kei1US2ZtVm1TZ2R4N1JPX1Exc3YzNDlmczJpWTFfdzRzVHBsTFhsZTd3WXYySnJRTGo4cTRFSmdPeV91S0NuS3IweWloRDR5eU9YeXozd0ZkM1NPbS15cklrYUFEazFJWmRXVmtFclUxMko5UXdDbGZHNlBwLXp4NkhlREhEZlFCSW4zVEZGMExGbm0?oc=5", "source_name": "GuruFocus", "published_at": "2026-06-17T16:46:32+00:00", "published_display": "17 Jun 2026 16:46", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Stock Surges After 70% ProSense Install Increase", "summary": "IceCure Medical (NASDAQ: ICCM) stock surged after the company announced a 70% increase in its U.S. ProSense install base following FDA marketing authorization in October 2025. This growth reflects accelerated commercial adoption, rising physician demand, and broader expansion int", "url": "https://www.benzinga.com/trading-ideas/movers/26/06/53256818/icecure-stock-surges-after-70-prosense-install-increase", "source_name": "Benzinga", "published_at": "2026-06-17T17:10:51", "published_display": "17 Jun 2026 17:10", "sentiment": "positive", "sentiment_pct": 70, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure lands $5.5M healthcare investor deal at a premium", "summary": "IceCure Medical Ltd. (ICCM) announced a private placement totaling $5.5 million with a single healthcare institutional investor. The deal involves the sale of ordinary shares, Series D warrants, and Series E warrants at a combined purchase price of $3.00 per share, a premium to i", "url": "https://www.stocktitan.net/news/ICCM/ice-cure-announces-pricing-of-5-5-million-private-placement-priced-a1zjpz2njjzw.html", "source_name": "Stock Titan", "published_at": "2026-06-17T17:10:51", "published_display": "17 Jun 2026 17:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Announces Pricing of $5.5 Million Private Placement Priced At a Premium to the Market Price with a Single Healthcare Focused Institutional Investor", "summary": "IceCure Medical (ICCM) has announced a $5.5 million private placement with a single healthcare-focused institutional investor. The placement involves the sale of ordinary shares and accompanying warrants at $3.00 per share, a premium to the Nasdaq closing price. The proceeds are ", "url": "https://www.prnewswire.com/news-releases/icecure-announces-pricing-of-5-5-million-private-placement-priced-at-a-premium-to-the-market-price-with-a-single-healthcare-focused-institutional-investor-302803416.html", "source_name": "PR Newswire", "published_at": "2026-06-17T17:10:50", "published_display": "17 Jun 2026 17:10", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICCM Stock On Track For Best Day In Nearly 5 Years \u2014 What\u2019s Driving The 200% Rally?", "summary": "Shares of IceCure Medical Ltd. (ICCM) surged over 200% on Wednesday following positive news about the accelerated adoption of its ProSense system in the U.S. The company reported a 70% increase in active U.S. commercial installs of ProSense since its FDA marketing authorization i", "url": "https://www.tradingview.com/news/stocktwits:7d4e3056f094b:0-iccm-stock-on-track-for-best-day-in-nearly-5-years-what-s-driving-the-200-rally/", "source_name": "TradingView", "published_at": "2026-06-17T16:39:52", "published_display": "17 Jun 2026 16:39", "sentiment": "positive", "sentiment_pct": 90, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Medical jumps on U.S. ProSense install base growth after FDA clearance", "summary": "IceCure Medical shares surged after the company announced a 70% increase in the U.S. commercial install base for its ProSense cryoablation system in breast cancer since FDA marketing approval in October 2025. This growth follows a 1-for-30 reverse stock split aimed at regaining N", "url": "https://ts2.tech/en/icecure-medical-jumps-on-u-s-prosense-install-base-growth-after-fda-clearance/", "source_name": "TechStock\u00b2", "published_at": "2026-06-17T16:10:52", "published_display": "17 Jun 2026 16:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Medical surges after update on U.S. ProSense adoption following FDA breast-cancer authorization", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxQTXZ0aE9EdVR2aFBDSHQ2N2VQODNENVVQMHV0TzNhQ1VtNW1KeXFfVi1QVkJTdUN2ZTZ4Qm1yTUN5YkFRTzMydUI0enNGWGZLd3NpRUdiTjZ5aVZTaWVYVnVkb3ZraktCcHkyWFFRLVpTMWNUYzNfaHZEZFBEOW01RW5uT3NsdER2dHBpRFpWYXNQdmttSTFGYzBUZ3JNVC0yU3cxcWNjSFduV1h0RFlMVWhzTjl3SjNISGUyeUlqc2xZSXFpXzBIWnVMUTh6dDM1THc?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-17T14:51:00+00:00", "published_display": "17 Jun 2026 14:51", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why is IceCure Medical stock surging today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOeFY4N0FsNWpJY19sZXV5QnV1dGZlRDdfNTNHN1NIVmRNdm5zUklMc2s4Mm15TGtJWElzOXhMQWdhOTBMWXdUQTVvNWFoSjhkVi0wdVo4Z0c0dldjVURVYW1NdnZWTEJsLWk2cGdWN1JLWEVENnhGSGMwak51aFJxMzR2djNoQUhNbnpHRXh1enVIZjYwdExUOEQ3MnFHZTNQYVBWZXoydw?oc=5", "source_name": "Investing.com", "published_at": "2026-06-17T13:15:31+00:00", "published_display": "17 Jun 2026 13:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICCM Stock Explodes As New Cancer Data Fuels Trading Frenzy", "summary": "IceCure Medical Ltd. (ICCM) stock surged by 235.21% due to positive clinical data for its ProSense cryoablation system, including nearly 90% recurrence-free outcomes in small kidney tumors and promising results in breast cancer and fibroadenomas. This data, coupled with recent FD", "url": "https://stockstotrade.com/news/icecure-medical-ltd-iccm-news-2026_06_17/", "source_name": "StocksToTrade", "published_at": "2026-06-17T14:10:52", "published_display": "17 Jun 2026 14:10", "sentiment": "positive", "sentiment_pct": 95, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FDA clearance drives 70% jump in IceCure\u2019s U.S. ProSense base", "summary": "IceCure (NASDAQ: ICCM) reported a 70% increase in its active U.S. commercial install base for the ProSense\u00ae system, used for breast cancer cryoablation, following FDA marketing authorization in October 2025. This growth is attributed to updated ASBrS clinical guidance, increased ", "url": "https://www.stocktitan.net/news/ICCM/ice-cure-reports-70-growth-in-active-u-s-commercial-install-base-for-7p3jrjv4vgh2.html", "source_name": "Stock Titan", "published_at": "2026-06-17T12:39:52", "published_display": "17 Jun 2026 12:39", "sentiment": "positive", "sentiment_pct": 59, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T14:49:04+00:00", "published_display": "16 Jun 2026 14:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Stocks Q1 Earnings: STAAR Surgical (NASDAQ:STAA) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgJBVV95cUxOMV82Sjl0aF9hd3gxUmliWk5Jbk1nb01jcGRva1ByQm5JWVVMUWMzVkxqREwwam9pLWRWUldWa3pNOEJPRGtjSVpaRXlseFBlSVQxM2pSRm92NFBITXdVLVNRRm5fczFEcHFtNC1GTWVaLS1Lekp6dU1BdzJqWEtpZ0J3QmJIY0pxUlhaMGh3RzIyUGZ5SWo5QWJySzFUSnp4cVZTTVlCdjhHMld0dGVxbENub01kb0NfVVhnY2F5YzUwRUM5MU8xNmxoVXE4RTFxRnB2bFY4M1JzYlN0cDZJcDJxUnByS0ZEVC1IMU9CN3RQN0dsM09ucDhsdHdwUTZseklZcEdiWngtUm1GeEdUVUUxVF90SndQaEE?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Icecure Medical Analyst Ratings and Price Targets | NASDAQ:ICCM", "summary": "Icecure Medical (NASDAQ: ICCM) has a consensus price target of $2.13 based on ratings from three analysts, with a high of $2.90 and a low of $1.00. The average price target from the three most recent analyst ratings \u2014 Maxim Group and HC Wainwright & Co. \u2014 implies a significant do", "url": "https://www.benzinga.com/quote/ICCM/analyst-ratings", "source_name": "Benzinga", "published_at": "2026-06-05T15:39:48", "published_display": "05 Jun 2026 15:39", "sentiment": "negative", "sentiment_pct": 40, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Medical to boost share price with 1-for-30 reverse split to regain NASDAQ compliance", "summary": "IceCure Medical (ICCM) announced a 1-for-30 reverse stock split to increase its share price and regain compliance with Nasdaq's minimum bid price requirement. The reverse stock split is expected to become effective around June 12, 2026, with trading on a split-adjusted basis comm", "url": "https://www.msn.com/en-us/money/companies/icecure-medical-to-boost-share-price-with-1-for-30-reverse-split-to-regain-nasdaq-compliance/ar-AA24Ei2A?apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1", "source_name": "MSN", "published_at": "2026-06-03T01:39:53", "published_display": "03 Jun 2026 01:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Medical (ICCM) Announces 1-for-30 Reverse Stock Split to Maintain Nasdaq Listing", "summary": "IceCure Medical (ICCM) has announced a 1-for-30 reverse stock split, effective June 4, 2026, to raise its stock price above Nasdaq's minimum $1 bid requirement and maintain its listing. The split will reduce outstanding shares from 84.2 million to approximately 2.8 million, with ", "url": "https://www.gurufocus.com/news/8896336/icecure-medical-iccm-announces-1for30-reverse-stock-split-to-maintain-nasdaq-listing?mobile=true", "source_name": "GuruFocus", "published_at": "2026-06-03T01:39:53", "published_display": "03 Jun 2026 01:39", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Medical (ICCM) Announces 1-for-30 Reverse Stock Split to Meet Nasdaq Requirements", "summary": "IceCure Medical (ICCM) has announced a 1-for-30 reverse stock split to meet Nasdaq's minimum bid price requirement of $1.00 per share. The company, which specializes in cryoablation technology, is considered undervalued by GuruFocus with a GF Value of $0.72 against a current pric", "url": "https://www.gurufocus.com/news/8896779/icecure-medical-iccm-announces-1for30-reverse-stock-split-to-meet-nasdaq-requirements", "source_name": "GuruFocus", "published_at": "2026-06-02T19:39:13", "published_display": "02 Jun 2026 19:39", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Medical (NASDAQ: ICCM) implements 1-for-30 reverse share split for Nasdaq", "summary": "IceCure Medical (NASDAQ: ICCM) is implementing a 1-for-30 reverse share split to regain compliance with Nasdaq's $1.00 minimum bid price requirement. The split will reduce outstanding shares from approximately 84.2 million to 2.8 million and will commence trading on a split-adjus", "url": "https://www.stocktitan.net/sec-filings/ICCM/6-k-ice-cure-medical-ltd-current-report-foreign-issuer-d0a3bfcfdaff.html", "source_name": "Stock Titan", "published_at": "2026-06-02T13:39:13", "published_display": "02 Jun 2026 13:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Medical Announces 1-for-30 Reverse Share Split to Support Nasdaq Compliance", "summary": "IceCure Medical Ltd. has announced a 1-for-30 reverse share split to proactively regain compliance with Nasdaq's $1.00 minimum bid price requirement. The split will take effect on June 4, 2026, and will adjust the number of outstanding shares from approximately 84.2 million to 2.", "url": "https://www.prnewswire.com/news-releases/icecure-medical-announces-1-for-30-reverse-share-split-to-support-nasdaq-compliance-302788487.html", "source_name": "PR Newswire", "published_at": "2026-06-02T12:29:36", "published_display": "02 Jun 2026 12:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure consolidates shares 30-to-1 in bid to keep Nasdaq listing", "summary": "IceCure Medical (ICCM) announced a 1-for-30 reverse share split to regain compliance with Nasdaq's $1.00 minimum bid price requirement. The split will reduce outstanding shares from approximately 84.2 million to 2.8 million and will be effective on June 4, 2026. Despite recent po", "url": "https://www.stocktitan.net/news/ICCM/ice-cure-medical-announces-1-for-30-reverse-share-split-to-support-qt7v8zfm47si.html", "source_name": "Stock Titan", "published_at": "2026-06-02T12:29:36", "published_display": "02 Jun 2026 12:29", "sentiment": "negative", "sentiment_pct": 36, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical device and healthcare services stocks lead sector's EPS revision rankings (XLV:NYSEARCA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxNZnFWTDRydm9EWGtDcm5yaG5mejNsM0FyMUdKeV9WcHVjQzVEVzRScDBUdHh2d3JyY0hZR0FvTzBDTWJTaEZSMk5yTlhqaWVLczNleHdKeVVDV0VWWmt0eGhiZFNLclNuOXhHYU50MUJVd09HY3ZkeHJRMHU3LUxMYzZkZWZOWW1RZnlOdUFSUUxadEZLX2ZmTVI1bE52QjdWS3RXd1FJUEVzVHE2ZjRUbTRGbE16OFJTNUE?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Number of shareholders of IceCure Medical Ltd. \u2013 BOATS:ICCM", "summary": "This article focuses on IceCure Medical Ltd. (ICCM) listed on the Blue Ocean Alternative Trade System (BOATS). It specifically aims to provide information regarding the number of shareholders for the company, although the content section for this data is currently empty. The arti", "url": "https://www.tradingview.com/symbols/BOATS-ICCM/financials-statistics-and-ratios/number-of-shareholders/", "source_name": "TradingView", "published_at": "2026-05-29T14:09:10", "published_display": "29 May 2026 14:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 4] IceCure Medical Ltd. Insider Trading Activity", "summary": "This article reports on an insider trading activity filing (Form 4) for IceCure Medical Ltd. (ICCM) dated May 18, 2026. The filing indicates that Ronen Tsimerman, the former Chief Financial Officer, ceased serving in his role on May 17, 2026, and is therefore no longer subject to", "url": "https://www.stocktitan.net/sec-filings/ICCM/form-4-ice-cure-medical-ltd-insider-trading-activity-3d24eb8b2541.html", "source_name": "Stock Titan", "published_at": "2026-05-21T22:39:53", "published_display": "21 May 2026 22:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Icecure Medical Ltd (ICCM) Q1 2026 Earnings Call Highlights: Robust Revenue Growth and ...", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/icecure-medical-ltd-iccm-q1-010030382.html", "source_name": "GuruFocus.com", "published_at": "2026-05-21T01:00:30+00:00", "published_display": "21 May 2026 01:00", "sentiment": "positive", "sentiment_pct": 58, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Medical Ltd. Reports Nearly 90% Recurrence-Free Rate For Cryoablation Of Kidney Cancer And Showcases ProSense At ECIO 2026", "summary": "IceCure Medical Ltd. announced impressive results for its ProSense cryoablation system at ECIO 2026, highlighting an 89.4% recurrence-free rate for kidney cancer patients with tumors measuring 3 cm or less. The company also showcased positive data for breast cancer and fibroadeno", "url": "https://www.marketscreener.com/news/icecure-medical-ltd-reports-nearly-90-recurrence-free-rate-for-cryoablation-of-kidney-cancer-and-s-ce7f5adedb8ff524", "source_name": "www.marketscreener.com", "published_at": "2026-05-19T20:39:17", "published_display": "19 May 2026 20:39", "sentiment": "positive", "sentiment_pct": 70, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure's ProSense\u00ae Reports Nearly 90% Recurrence-Free Rate for Cryoablation of Kidney Cancer: Data Presented at ECIO 2026 and First-Ever Breast Cryoablation Master Class Overbooked", "summary": "IceCure Medical announced significant clinical data at ECIO 2026, highlighting the efficacy of its ProSense\u00ae cryoablation technology. The ICESECRET trial showed an 89.4% recurrence-free rate for kidney cancer patients with small tumors, while independent breast cancer studies rep", "url": "https://www.prnewswire.com/news-releases/icecures-prosense-reports-nearly-90-recurrence-free-rate-for-cryoablation-of-kidney-cancer-data-presented-at-ecio-2026-and-first-ever-breast-cryoablation-master-class-overbooked-302776063.html", "source_name": "PR Newswire", "published_at": "2026-05-19T19:39:55", "published_display": "19 May 2026 19:39", "sentiment": "positive", "sentiment_pct": 92, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Showcases Strong ProSense\u00ae Cryoablation Data and Surge in Clinical Interest at ECIO 2026", "summary": "IceCure Medical presented strong long-term data for its ProSense\u00ae cryoablation technology at ECIO 2026, including high recurrence-free rates for kidney cancer and safe, effective outcomes for breast cancer. The conference also saw an enthusiastic response to breast cryoablation t", "url": "https://www.tipranks.com/news/company-announcements/icecure-showcases-strong-prosense-cryoablation-data-and-surge-in-clinical-interest-at-ecio-2026", "source_name": "TipRanks", "published_at": "2026-05-19T13:40:36", "published_display": "19 May 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Medical (ICCM) highlights kidney and breast cryoablation data at ECIO 2026", "summary": "IceCure Medical announced new clinical data from its ProSense\u00ae cryoablation system for kidney and breast tumors, presented at ECIO 2026. The data showed an 89.4% recurrence-free rate in kidney cancer patients with tumors \u22643 cm and 83.9% overall at a 4-year follow-up. Independent ", "url": "https://www.stocktitan.net/sec-filings/ICCM/6-k-ice-cure-medical-ltd-current-report-foreign-issuer-fba5d00a40a1.html", "source_name": "Stock Titan", "published_at": "2026-05-19T12:40:36", "published_display": "19 May 2026 12:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Medical (ICCM) CFO reports 400,000 RSUs equity grant", "summary": "IceCure Medical Ltd.'s CFO, Peleg Meir, has been granted 400,000 restricted share units (RSUs) as part of his equity compensation. The RSUs have a multi-year vesting schedule, with 25% vesting on May 17, 2027, and the remaining 75% vesting in equal quarterly installments of 6.25%", "url": "https://www.stocktitan.net/sec-filings/ICCM/form-3-ice-cure-medical-ltd-initial-statement-of-beneficial-ownership-54cc3b5d36e2.html", "source_name": "Stock Titan", "published_at": "2026-05-18T11:38:58", "published_display": "18 May 2026 11:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxOTlRUVTVIUkMtWmhUSXEzX0RwdlJOUlZVblVNS3RXWV9ZNEoxR0JQNkhVZ2tncW9aMWN1anJNQjduZ1NvTjBaeXkySGpWQ1VrRnRWNHh3Z1FzWGZ6Vlk5RmtGaFZCOXp0RnlhSjJWVmVSY1hJdFlGbWZOOWlHSmQxUkcyZk9Jb3dKUE1JblRQRHVqZlk0dzU2S3cyTlktVDFBeVVxQTNaWWlMcmo2SHdkTF9zRWtxaTZZaDU4Um1kMVVsX2pwdlZhRXZtaElVcmhsTFp0VFExWHpKaXhvdXY4cGNKZw?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure (ICCM) Q1 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/74272ac2-6773-3276-85bb-cef87cd6241d/icecure-%28iccm%29-q1-2026.html", "source_name": "Motley Fool", "published_at": "2026-05-12T16:11:20+00:00", "published_display": "12 May 2026 16:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Reports First Quarter 2026 Financial Results: ProSense\u00ae Sales Increase Substantially in the U.S. and North America", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxQTU0yZW9LSFVKd2FFQ0NSelBWRkE3ck5CSy1QNElCdTJSMFpaWjJhZDI4bkt0NkJqcWVGd2JJQ0RiVXoyYkpKUXJIQkdtODBqZEJXQU81UFpQdWNfdzN0Qm1qUW5wLWtrT3pzNVNhN05kZ3JMUlJWLWp0ZGJ6bEFISzEtdnA4cFRwR1hHQXA2aXdFZ2pYNEQyUzhHbEpKY0c5c3NmSlhxRFdERktaalB1THVlY0dVMkdrbE95b1dESGoxcGhLWVZMSTdZcVBqWldEUEVXR21RV0VJNmFpNkpzOEtyc2tLekVkZGxuNUZ4bDRheWZCVGVTaWRfc2M0c091Z3VaMQ?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Medical Ltd. (ICCM) Reports Q1 Loss, Lags Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPdWJ5cEkzd2NzSUwtRDJfOC1KRGl2Z241MzNTOGwwVU0yUURIUjVBUkdVS0stV2pSenduRDBjeTlTVTVXWXBzellEWG9BN0dOQWdVUm02aWtoT3d1QXlQX3FHeTA5bjBSMi0wdWhUeENNUGpsTFlkdm9fOGVKOHV0bTEtM01PeG5NUXlCZVRMYmtaWkoyT1lpeXphOEpIZw?oc=5", "source_name": "Market source", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[6-K] IceCure Medical Ltd. Current Report (Foreign Issuer) | ICCM SEC Filing - Form 6-K", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxQd0pCMWxDeldiMVgzNEoyTUMtSE5fSHhMdWhPbHNyUHFQdk9fU09idXV2LVJDTUZTM3BGTmI0U0FzNGNYaXk4YnpRNms1WmFRYVVSVXotRWhLOXhEWENpQXZQOUJNYzFWMFhVam5RNjljdHdwTFZaRkJZNURLWVZYc2NuaVdwRnRhQ05oVjFicjhMQjQzLWdnUHgwUzNBUFZicDE2YTYyLTN5N0pnX1pHOG9DOGwwbk0?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Medical (ICCM) prices $4M share sale with concurrent warrants", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPRlkzS3NTYVcyRndZOFZmd01sanROT2ZhZzN5WjlnUWpfaVJlcUE3ZHZfWjduSFZNd3RWb3dwOVBFblI4YXpzbzROTFJLQmIwSmNxUGw4VkJTM3g3RDZ2MjVXa3dMMkl5TlNSSUxETzhiWXZmdTVFVzYzeXNsY1k4NWx5bG5BTmpWbDZHU3JjMFJ1aEwtN2FzVVU1c0txaWdLRGZ1cWhqdDdiQUtPdXlTODQ4OWZyaTg?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-27T07:00:00+00:00", "published_display": "27 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Announces Pricing of $4.0 Million Registered Direct Offering and Concurrent Private Placement", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxPdWpRN1ZwZ2l4STZXR2JSTVFlWkNiLVhNUDBKSXJhNU1LcWJHNjRORmVMRHc3d2lkWEkwc2tiQmZ2MHlHcXlDeHdDb0d5SkRoazM3TzhvQU0xSlBWa2lGY2xaRWhXdDVremZDdHZ2ZE96WFc1Y3dEdG9BYlJhMlFxRy12R0Y3SjVoTWV4V0R2eVFTY05XM1ROMGkwTFgwWnNxTHN3cWJrcHh6aml3ODlXb2lfMjdKaFp0ZkRTeEdpOHNTME1FNlJwY3VYQUJmeE8wWmdaWGdzd1lMa2E5XzkxSll6enE3UWlkMnhZeQ?oc=5", "source_name": "PR Newswire", "published_at": "2026-03-26T07:00:00+00:00", "published_display": "26 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[EFFECT] IceCure Medical Ltd. SEC Filing", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNVmlUaXNkbmNMcVNlbWxEQm8xRWMzRnNXS2NWUXhuQjRxdW5DcHlEaHEtOHhxemZLX2xpTFVLVGphVHBXY1phTi1SMzBjNlZIT0xBRTVwUm5Kd251WkFsX3IyMkd3R1ZRSVpxRWdMVlVDVzYtWS1UZWhOaTg1dWdWUEtBTVlIYzhWdDEzcUUyY28tTHFEWWxVbjFOZ215ZFRMT0E?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-24T07:00:00+00:00", "published_display": "24 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxQZXhDWktWZlhhSHlxNVZrNWllaDhhWlNXZmhKYlQ4ODRJMHozNTR2TVVKSWVrQV94bzNNU0hfVW5qODRlWW01anFmTG5SYmZoUlJpU09UbkpSemxVbHRGb1F1MGVvZFdqSEVBcUZ5Ti1ZVHlzY3pZYTdCS21RcDJPTnppdWRKVlZjd2ZUeA?oc=5", "source_name": "Market source", "published_at": "2026-03-17T07:00:00+00:00", "published_display": "17 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "U.S. FDA Approves IceCure's Post-Marketing \"ChoICE\" Study for ProSense\u00ae Cryoablation in the Local Treatment of Low-Risk Breast Cancer", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAJBVV95cUxQNkRnRkRMWVJYQjhWTVRRbUdudW1xYlp4S2FsWUpBZWRsVW9ROXVMNVkwcjY3WXd4QUVvOUE5SFNlMnBwU2M5YV9wNWdtX3IwYjcyU204ekkzd3ZxU2ZIdFBiRzlxYnpxV3Z4eXRwSjNxQTFBRUk5WUhMWG1wZ2YwM1E5REhJN3dfQnhLQ3ZWUnNhRUQtTkRRZ2JEQ1ZRZm9XUXd1cXA2S2ozaGd5SjhjbjladWZFMFlZV29Da1RJUFV3YVUtd0QzSkROX2Z3a25EeUZVaGlmS0dyWUhGR1plcm10WW5ZYXpFd0QwVWlhSEgtajVNSlZsRFZadmZrUG9Uay1tNVAxcUZ3MG0tbmFSWHVoR04?oc=5", "source_name": "PR Newswire", "published_at": "2026-03-11T07:00:00+00:00", "published_display": "11 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Lantheus (NASDAQ:LNTH) Vs The Rest Of The Medical Devices & Supplies - Imaging, Diagnostics Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxORnRwNHkwQmJ3Nl9famF1aktWdDdLV2ZfNjFCVm9WSFJrQTRSMURQUEJrMGtZUTFiVEtZWGxyUWwwai04Zk4wZ2pTWXFsLUozTzR2Ykd5UUREenZmSTRWdzJPODNONWFCWUVoVlBuTmtVSnpWQXFOVEVMdWNDLWNfRnRqRWdweElVS2pabQ?oc=5", "source_name": "Market source", "published_at": "2026-03-11T07:00:00+00:00", "published_display": "11 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Winners And Losers Of Q4: Stryker (NYSE:SYK) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxPQVE1TUY2VFFCTHQ0cUpnUWVkOWdGbnRCUnF0VXpQdDYzcGlWVm5ZZHJ1MF85V3NlX0gxbXppZmRXTTFyRk5OclBuQndmMlg0alAzYUp3T2Jaa2VYdzBiZzFYby1SMnlWVlBkSkw4RzRHZjY5bFdqeUpXYk1tOHVQeGtn?oc=5", "source_name": "Market source", "published_at": "2026-03-11T07:00:00+00:00", "published_display": "11 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Specialty Stocks\u2019 Q4 Earnings: Haemonetics (NYSE:HAE) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxQcXUxeEZpRzE0aXJ0RVlrVXZMdF9pSEV3VTROeDNWdjNZZWVDNVhKZU9BRFpIOWlZYzJrU1RZVzFDLUZhRDBjY0pBdVB2YVJUNVZvZEhubmd1OXlobFJaUWxVbUtlVEFwdWNVQnRqMDBHbEFubzBpczN1Zi1mN0xFbC1pTHpqZzA?oc=5", "source_name": "Market source", "published_at": "2026-03-06T08:00:00+00:00", "published_display": "06 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q4 Highlights: Merit Medical Systems (NASDAQ:MMSI)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxQdTQyU1EtSEFYQTdZR0NhU1ZpMVdGNXhiTnlkNm9RWFRka3RfYlZBeklfTFZTRkVaOHBGNi15enNqMGlxVnJad0M5cmp3dUZzYW9Va2tOU19sMnE4V1czcFB4VWRKaVBzYnRtZ0RfVnB5TkloY3U5dW4wQllJMDJaS3BQSVNOMHlVRFQ4aDYtSV9HNTViZXc?oc=5", "source_name": "Market source", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Freezing benign breast tumors shrank them 93% in new IceCure study", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxORkRweVN5cGVFY0V2M0xINDR0b2hpY2pwaWxqTmR3a1REamVMaF9jMEpNM1l5WkRGQXpwNGVmMjJpbWpKQndxcEFiREM4LUVfUEdyMXNfOFBSVmxnM0g1LXB2V3oyMl8wcERiS0lGSnpUMU5nQjJrNkJZY242U2VtXzBnWTJTNmxvZHhlY3FJV2JZWVpuWjZ0Z1FCcEZmRjZBWTdQQzQ4VFJUVEZ2R3FsOXNZbVBvT0lzaWY4?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOb3BiQVNFREdNblk2QS10b1lhRUtfb05vU2VFZHB5V0hJT0R4NmhwQWRrcFVsR3UwMjZleFV6N2FEelpZVzY3YWFxSWE1cWpLaTFrQVU4NktkQUloUkxaV3ZTVkh6b1ZmaDdMN2ViX1BUNE4xUTNUZFNlR0syVGlZSg?oc=5", "source_name": "Market source", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q3 Earnings: Inspire Medical Systems (NYSE:INSP) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgJBVV95cUxOekhIMGs0UXlrdHhudkYzRWhSXzBNazdMLXBSTnd5dEFTZDR3MkdBc1AtNUNrcmp4Z1IxNVBuZVJJejdkdjdwT1Zoc0NudGMxVGNjRGxaUGVrYncxekxMNWV5RGlNNjZWUW9vdzdwaVRtTlMzcFl0MWRZNDlTY0xWWkNteE9fTU9LMm5aX1VuSll2UTNONzRqNnVpYXRvbDVIX1lXaGJMV3JKZFltUTVPNVpUc2Q0MHdYVUUydmZUMVo4dDIzLUxjZk53c1J1bDcxTXJWa0VNZXdJanZfbUVHcmgwamRwaGJyc1pXeGhtZ1dnaTJMN2JCeHlJLUFCZXRaVFhaUHozVi1wRlQ1dkE?oc=5", "source_name": "StockStory", "published_at": "2026-01-28T08:00:00+00:00", "published_display": "28 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "When Will IceCure Medical Ltd (NASDAQ:ICCM) Turn A Profit?", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxNejkwTXhIaUtyUFV6N0FrejdMN1JZTFhxaUtKOTdtTjJka2F3MG9oWVpEMDVjdlpsUmdHemRGVER0dXlJdGM1aE9BSmlHSDRpTGZHUW5pbnpHM3diWVZ1bnJ2SVBaR1EzZzhjaE5HRVdCMm13dDlhbTRuX0V3MndmbEtPNA?oc=5", "source_name": "Market source", "published_at": "2026-01-15T08:00:00+00:00", "published_display": "15 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "This Undervalued Medical-Devices Stock Is Poised for a Rebound", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPN1g2RjVsUTVvTmdXRTdJMTRpVTlOQnZIbm9hTWJDdkRaeVpINjFqbXpDUVFpMVdYMExyR2VQQVNpZ3p0V2F1SVJMelpJZWk1bExvb0dYWnJ4VVJJRURseEVQVVZwNnRZREZiQzlFTHlhSHFadGdXRmpxbXA2XzBMNA?oc=5", "source_name": "Barron's", "published_at": "2026-06-22T15:45:00+00:00", "published_display": "22 Jun 2026 15:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Has IceCure Medical's Stock Price Collapsed", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxQU01wa1MxYlVZeWRHWjE0RFFSQzNXdXFaMkQ5MUNLWmxHVDlfaHNFZnJENnlYRHp1WGtHcDF2TXdpNWtOQ2gyX2EzYVlLQ2pGNzJQc3lzQUR2QlVIV3BkZ0dObjZWWWRkOW95dWdqdjdzbUtTM19ITTQtbl90ZWt5R0pKV3RaVGVXNEE?oc=5", "source_name": "Kavout", "published_at": "2026-06-21T06:37:57+00:00", "published_display": "21 Jun 2026 06:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Medical (ICCM) prices $5.5M private placement with warrant package", "summary": "IceCure Medical (ICCM) has priced a $5.5 million private placement with a single institutional investor, involving the issuance of pre-funded warrants and new Series D and E warrants. The company also announced a 70% increase in its active U.S. commercial ProSense\u00ae install base f", "url": "https://www.stocktitan.net/sec-filings/ICCM/6-k-ice-cure-medical-ltd-current-report-foreign-issuer-b70b1f4d7cc5.html", "source_name": "Stock Titan", "published_at": "2026-06-18T21:11:49", "published_display": "18 Jun 2026 21:11", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Medical gains after ProSense update, $5.5M placement", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxQdHZEY1Z3T1ZtTXpTVGV4emZYMGVRNzRzbExIWEk3eFItemlWbVlUXzJ6cjZINzlXWkw2Zm5LZndVaWNBMVk0aXdGSGt2eEpIUE91ZnFfVlVDaEdBOFpIdWJtS01CNno4T3Q1bDRHMUV5NWh2bmVrYVllbkpvaGNJdTFLNzg4UQ?oc=5", "source_name": "TechStock\u00b2", "published_at": "2026-06-18T12:00:34+00:00", "published_display": "18 Jun 2026 12:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tumour freezing specialist IceCure Medical skyrockets from latest successes", "summary": "IceCure Medical Ltd (NASDAQ: ICCM), a company specializing in cryoablation technology for tumors, has seen its shares soar after announcing a 70% increase in its US commercial install base for its ProSense system and a US$5.5 million private placement. The ProSense system uses li", "url": "https://mugglehead.com/tumour-freezing-specialist-icecure-medical-skyrockets-from-latest-successes/", "source_name": "Mugglehead Investment Magazine", "published_at": "2026-06-18T08:40:07", "published_display": "18 Jun 2026 08:40", "sentiment": "positive", "sentiment_pct": 91, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Reports 70% Growth in Active U.S. Commercial Install Base for Breast Cancer Cryoablation Following FDA Clearance", "summary": "IceCure Medical Ltd. reported a 70% increase in its U.S. active commercial install base for ProSense\u00ae breast cancer cryoablation systems since receiving FDA marketing authorization in October 2025. This growth is attributed to accelerating commercial adoption, expanding physician", "url": "https://www.streetinsider.com/PRNewswire/IceCure+Reports+70%25+Growth+in+Active+U.S.+Commercial+Install+Base+for+Breast+Cancer+Cryoablation+Following+FDA+Clearance/26657255.html", "source_name": "StreetInsider", "published_at": "2026-06-17T20:10:26", "published_display": "17 Jun 2026 20:10", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Medical Shares Jump After Update on Commercial Adoption of Breast Cancer Cryoablation Procedures", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/icecure-medical-shares-jump-commercial-180907961.html", "source_name": "MT Newswires", "published_at": "2026-06-17T18:09:07+00:00", "published_display": "17 Jun 2026 18:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Medical (ICCM) Sees 70% Surge in Cryoablation Install Ba", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPMEtDSlQ2QU9JTHZwNk85c1I4a1A5d1dxaWdtNm0tZW5Kei1US2ZtVm1TZ2R4N1JPX1Exc3YzNDlmczJpWTFfdzRzVHBsTFhsZTd3WXYySnJRTGo4cTRFSmdPeV91S0NuS3IweWloRDR5eU9YeXozd0ZkM1NPbS15cklrYUFEazFJWmRXVmtFclUxMko5UXdDbGZHNlBwLXp4NkhlREhEZlFCSW4zVEZGMExGbm0?oc=5", "source_name": "GuruFocus", "published_at": "2026-06-17T16:46:32+00:00", "published_display": "17 Jun 2026 16:46", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Stock Surges After 70% ProSense Install Increase", "summary": "IceCure Medical (NASDAQ: ICCM) stock surged after the company announced a 70% increase in its U.S. ProSense install base following FDA marketing authorization in October 2025. This growth reflects accelerated commercial adoption, rising physician demand, and broader expansion int", "url": "https://www.benzinga.com/trading-ideas/movers/26/06/53256818/icecure-stock-surges-after-70-prosense-install-increase", "source_name": "Benzinga", "published_at": "2026-06-17T17:10:51", "published_display": "17 Jun 2026 17:10", "sentiment": "positive", "sentiment_pct": 70, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure lands $5.5M healthcare investor deal at a premium", "summary": "IceCure Medical Ltd. (ICCM) announced a private placement totaling $5.5 million with a single healthcare institutional investor. The deal involves the sale of ordinary shares, Series D warrants, and Series E warrants at a combined purchase price of $3.00 per share, a premium to i", "url": "https://www.stocktitan.net/news/ICCM/ice-cure-announces-pricing-of-5-5-million-private-placement-priced-a1zjpz2njjzw.html", "source_name": "Stock Titan", "published_at": "2026-06-17T17:10:51", "published_display": "17 Jun 2026 17:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Announces Pricing of $5.5 Million Private Placement Priced At a Premium to the Market Price with a Single Healthcare Focused Institutional Investor", "summary": "IceCure Medical (ICCM) has announced a $5.5 million private placement with a single healthcare-focused institutional investor. The placement involves the sale of ordinary shares and accompanying warrants at $3.00 per share, a premium to the Nasdaq closing price. The proceeds are ", "url": "https://www.prnewswire.com/news-releases/icecure-announces-pricing-of-5-5-million-private-placement-priced-at-a-premium-to-the-market-price-with-a-single-healthcare-focused-institutional-investor-302803416.html", "source_name": "PR Newswire", "published_at": "2026-06-17T17:10:50", "published_display": "17 Jun 2026 17:10", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICCM Stock On Track For Best Day In Nearly 5 Years \u2014 What\u2019s Driving The 200% Rally?", "summary": "Shares of IceCure Medical Ltd. (ICCM) surged over 200% on Wednesday following positive news about the accelerated adoption of its ProSense system in the U.S. The company reported a 70% increase in active U.S. commercial installs of ProSense since its FDA marketing authorization i", "url": "https://www.tradingview.com/news/stocktwits:7d4e3056f094b:0-iccm-stock-on-track-for-best-day-in-nearly-5-years-what-s-driving-the-200-rally/", "source_name": "TradingView", "published_at": "2026-06-17T16:39:52", "published_display": "17 Jun 2026 16:39", "sentiment": "positive", "sentiment_pct": 90, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Medical jumps on U.S. ProSense install base growth after FDA clearance", "summary": "IceCure Medical shares surged after the company announced a 70% increase in the U.S. commercial install base for its ProSense cryoablation system in breast cancer since FDA marketing approval in October 2025. This growth follows a 1-for-30 reverse stock split aimed at regaining N", "url": "https://ts2.tech/en/icecure-medical-jumps-on-u-s-prosense-install-base-growth-after-fda-clearance/", "source_name": "TechStock\u00b2", "published_at": "2026-06-17T16:10:52", "published_display": "17 Jun 2026 16:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Medical surges after update on U.S. ProSense adoption following FDA breast-cancer authorization", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxQTXZ0aE9EdVR2aFBDSHQ2N2VQODNENVVQMHV0TzNhQ1VtNW1KeXFfVi1QVkJTdUN2ZTZ4Qm1yTUN5YkFRTzMydUI0enNGWGZLd3NpRUdiTjZ5aVZTaWVYVnVkb3ZraktCcHkyWFFRLVpTMWNUYzNfaHZEZFBEOW01RW5uT3NsdER2dHBpRFpWYXNQdmttSTFGYzBUZ3JNVC0yU3cxcWNjSFduV1h0RFlMVWhzTjl3SjNISGUyeUlqc2xZSXFpXzBIWnVMUTh6dDM1THc?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-17T14:51:00+00:00", "published_display": "17 Jun 2026 14:51", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why is IceCure Medical stock surging today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOeFY4N0FsNWpJY19sZXV5QnV1dGZlRDdfNTNHN1NIVmRNdm5zUklMc2s4Mm15TGtJWElzOXhMQWdhOTBMWXdUQTVvNWFoSjhkVi0wdVo4Z0c0dldjVURVYW1NdnZWTEJsLWk2cGdWN1JLWEVENnhGSGMwak51aFJxMzR2djNoQUhNbnpHRXh1enVIZjYwdExUOEQ3MnFHZTNQYVBWZXoydw?oc=5", "source_name": "Investing.com", "published_at": "2026-06-17T13:15:31+00:00", "published_display": "17 Jun 2026 13:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ICCM Stock Explodes As New Cancer Data Fuels Trading Frenzy", "summary": "IceCure Medical Ltd. (ICCM) stock surged by 235.21% due to positive clinical data for its ProSense cryoablation system, including nearly 90% recurrence-free outcomes in small kidney tumors and promising results in breast cancer and fibroadenomas. This data, coupled with recent FD", "url": "https://stockstotrade.com/news/icecure-medical-ltd-iccm-news-2026_06_17/", "source_name": "StocksToTrade", "published_at": "2026-06-17T14:10:52", "published_display": "17 Jun 2026 14:10", "sentiment": "positive", "sentiment_pct": 95, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FDA clearance drives 70% jump in IceCure\u2019s U.S. ProSense base", "summary": "IceCure (NASDAQ: ICCM) reported a 70% increase in its active U.S. commercial install base for the ProSense\u00ae system, used for breast cancer cryoablation, following FDA marketing authorization in October 2025. This growth is attributed to updated ASBrS clinical guidance, increased ", "url": "https://www.stocktitan.net/news/ICCM/ice-cure-reports-70-growth-in-active-u-s-commercial-install-base-for-7p3jrjv4vgh2.html", "source_name": "Stock Titan", "published_at": "2026-06-17T12:39:52", "published_display": "17 Jun 2026 12:39", "sentiment": "positive", "sentiment_pct": 59, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T14:49:04+00:00", "published_display": "16 Jun 2026 14:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Stocks Q1 Earnings: STAAR Surgical (NASDAQ:STAA) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgJBVV95cUxOMV82Sjl0aF9hd3gxUmliWk5Jbk1nb01jcGRva1ByQm5JWVVMUWMzVkxqREwwam9pLWRWUldWa3pNOEJPRGtjSVpaRXlseFBlSVQxM2pSRm92NFBITXdVLVNRRm5fczFEcHFtNC1GTWVaLS1Lekp6dU1BdzJqWEtpZ0J3QmJIY0pxUlhaMGh3RzIyUGZ5SWo5QWJySzFUSnp4cVZTTVlCdjhHMld0dGVxbENub01kb0NfVVhnY2F5YzUwRUM5MU8xNmxoVXE4RTFxRnB2bFY4M1JzYlN0cDZJcDJxUnByS0ZEVC1IMU9CN3RQN0dsM09ucDhsdHdwUTZseklZcEdiWngtUm1GeEdUVUUxVF90SndQaEE?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Icecure Medical Analyst Ratings and Price Targets | NASDAQ:ICCM", "summary": "Icecure Medical (NASDAQ: ICCM) has a consensus price target of $2.13 based on ratings from three analysts, with a high of $2.90 and a low of $1.00. The average price target from the three most recent analyst ratings \u2014 Maxim Group and HC Wainwright & Co. \u2014 implies a significant do", "url": "https://www.benzinga.com/quote/ICCM/analyst-ratings", "source_name": "Benzinga", "published_at": "2026-06-05T15:39:48", "published_display": "05 Jun 2026 15:39", "sentiment": "negative", "sentiment_pct": 40, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Medical to boost share price with 1-for-30 reverse split to regain NASDAQ compliance", "summary": "IceCure Medical (ICCM) announced a 1-for-30 reverse stock split to increase its share price and regain compliance with Nasdaq's minimum bid price requirement. The reverse stock split is expected to become effective around June 12, 2026, with trading on a split-adjusted basis comm", "url": "https://www.msn.com/en-us/money/companies/icecure-medical-to-boost-share-price-with-1-for-30-reverse-split-to-regain-nasdaq-compliance/ar-AA24Ei2A?apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1", "source_name": "MSN", "published_at": "2026-06-03T01:39:53", "published_display": "03 Jun 2026 01:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Medical (ICCM) Announces 1-for-30 Reverse Stock Split to Maintain Nasdaq Listing", "summary": "IceCure Medical (ICCM) has announced a 1-for-30 reverse stock split, effective June 4, 2026, to raise its stock price above Nasdaq's minimum $1 bid requirement and maintain its listing. The split will reduce outstanding shares from 84.2 million to approximately 2.8 million, with ", "url": "https://www.gurufocus.com/news/8896336/icecure-medical-iccm-announces-1for30-reverse-stock-split-to-maintain-nasdaq-listing?mobile=true", "source_name": "GuruFocus", "published_at": "2026-06-03T01:39:53", "published_display": "03 Jun 2026 01:39", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Medical (ICCM) Announces 1-for-30 Reverse Stock Split to Meet Nasdaq Requirements", "summary": "IceCure Medical (ICCM) has announced a 1-for-30 reverse stock split to meet Nasdaq's minimum bid price requirement of $1.00 per share. The company, which specializes in cryoablation technology, is considered undervalued by GuruFocus with a GF Value of $0.72 against a current pric", "url": "https://www.gurufocus.com/news/8896779/icecure-medical-iccm-announces-1for30-reverse-stock-split-to-meet-nasdaq-requirements", "source_name": "GuruFocus", "published_at": "2026-06-02T19:39:13", "published_display": "02 Jun 2026 19:39", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Medical (NASDAQ: ICCM) implements 1-for-30 reverse share split for Nasdaq", "summary": "IceCure Medical (NASDAQ: ICCM) is implementing a 1-for-30 reverse share split to regain compliance with Nasdaq's $1.00 minimum bid price requirement. The split will reduce outstanding shares from approximately 84.2 million to 2.8 million and will commence trading on a split-adjus", "url": "https://www.stocktitan.net/sec-filings/ICCM/6-k-ice-cure-medical-ltd-current-report-foreign-issuer-d0a3bfcfdaff.html", "source_name": "Stock Titan", "published_at": "2026-06-02T13:39:13", "published_display": "02 Jun 2026 13:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Medical Announces 1-for-30 Reverse Share Split to Support Nasdaq Compliance", "summary": "IceCure Medical Ltd. has announced a 1-for-30 reverse share split to proactively regain compliance with Nasdaq's $1.00 minimum bid price requirement. The split will take effect on June 4, 2026, and will adjust the number of outstanding shares from approximately 84.2 million to 2.", "url": "https://www.prnewswire.com/news-releases/icecure-medical-announces-1-for-30-reverse-share-split-to-support-nasdaq-compliance-302788487.html", "source_name": "PR Newswire", "published_at": "2026-06-02T12:29:36", "published_display": "02 Jun 2026 12:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure consolidates shares 30-to-1 in bid to keep Nasdaq listing", "summary": "IceCure Medical (ICCM) announced a 1-for-30 reverse share split to regain compliance with Nasdaq's $1.00 minimum bid price requirement. The split will reduce outstanding shares from approximately 84.2 million to 2.8 million and will be effective on June 4, 2026. Despite recent po", "url": "https://www.stocktitan.net/news/ICCM/ice-cure-medical-announces-1-for-30-reverse-share-split-to-support-qt7v8zfm47si.html", "source_name": "Stock Titan", "published_at": "2026-06-02T12:29:36", "published_display": "02 Jun 2026 12:29", "sentiment": "negative", "sentiment_pct": 36, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical device and healthcare services stocks lead sector's EPS revision rankings (XLV:NYSEARCA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxNZnFWTDRydm9EWGtDcm5yaG5mejNsM0FyMUdKeV9WcHVjQzVEVzRScDBUdHh2d3JyY0hZR0FvTzBDTWJTaEZSMk5yTlhqaWVLczNleHdKeVVDV0VWWmt0eGhiZFNLclNuOXhHYU50MUJVd09HY3ZkeHJRMHU3LUxMYzZkZWZOWW1RZnlOdUFSUUxadEZLX2ZmTVI1bE52QjdWS3RXd1FJUEVzVHE2ZjRUbTRGbE16OFJTNUE?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Number of shareholders of IceCure Medical Ltd. \u2013 BOATS:ICCM", "summary": "This article focuses on IceCure Medical Ltd. (ICCM) listed on the Blue Ocean Alternative Trade System (BOATS). It specifically aims to provide information regarding the number of shareholders for the company, although the content section for this data is currently empty. The arti", "url": "https://www.tradingview.com/symbols/BOATS-ICCM/financials-statistics-and-ratios/number-of-shareholders/", "source_name": "TradingView", "published_at": "2026-05-29T14:09:10", "published_display": "29 May 2026 14:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 4] IceCure Medical Ltd. Insider Trading Activity", "summary": "This article reports on an insider trading activity filing (Form 4) for IceCure Medical Ltd. (ICCM) dated May 18, 2026. The filing indicates that Ronen Tsimerman, the former Chief Financial Officer, ceased serving in his role on May 17, 2026, and is therefore no longer subject to", "url": "https://www.stocktitan.net/sec-filings/ICCM/form-4-ice-cure-medical-ltd-insider-trading-activity-3d24eb8b2541.html", "source_name": "Stock Titan", "published_at": "2026-05-21T22:39:53", "published_display": "21 May 2026 22:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Icecure Medical Ltd (ICCM) Q1 2026 Earnings Call Highlights: Robust Revenue Growth and ...", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/icecure-medical-ltd-iccm-q1-010030382.html", "source_name": "GuruFocus.com", "published_at": "2026-05-21T01:00:30+00:00", "published_display": "21 May 2026 01:00", "sentiment": "positive", "sentiment_pct": 58, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Medical Ltd. Reports Nearly 90% Recurrence-Free Rate For Cryoablation Of Kidney Cancer And Showcases ProSense At ECIO 2026", "summary": "IceCure Medical Ltd. announced impressive results for its ProSense cryoablation system at ECIO 2026, highlighting an 89.4% recurrence-free rate for kidney cancer patients with tumors measuring 3 cm or less. The company also showcased positive data for breast cancer and fibroadeno", "url": "https://www.marketscreener.com/news/icecure-medical-ltd-reports-nearly-90-recurrence-free-rate-for-cryoablation-of-kidney-cancer-and-s-ce7f5adedb8ff524", "source_name": "www.marketscreener.com", "published_at": "2026-05-19T20:39:17", "published_display": "19 May 2026 20:39", "sentiment": "positive", "sentiment_pct": 70, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure's ProSense\u00ae Reports Nearly 90% Recurrence-Free Rate for Cryoablation of Kidney Cancer: Data Presented at ECIO 2026 and First-Ever Breast Cryoablation Master Class Overbooked", "summary": "IceCure Medical announced significant clinical data at ECIO 2026, highlighting the efficacy of its ProSense\u00ae cryoablation technology. The ICESECRET trial showed an 89.4% recurrence-free rate for kidney cancer patients with small tumors, while independent breast cancer studies rep", "url": "https://www.prnewswire.com/news-releases/icecures-prosense-reports-nearly-90-recurrence-free-rate-for-cryoablation-of-kidney-cancer-data-presented-at-ecio-2026-and-first-ever-breast-cryoablation-master-class-overbooked-302776063.html", "source_name": "PR Newswire", "published_at": "2026-05-19T19:39:55", "published_display": "19 May 2026 19:39", "sentiment": "positive", "sentiment_pct": 92, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Showcases Strong ProSense\u00ae Cryoablation Data and Surge in Clinical Interest at ECIO 2026", "summary": "IceCure Medical presented strong long-term data for its ProSense\u00ae cryoablation technology at ECIO 2026, including high recurrence-free rates for kidney cancer and safe, effective outcomes for breast cancer. The conference also saw an enthusiastic response to breast cryoablation t", "url": "https://www.tipranks.com/news/company-announcements/icecure-showcases-strong-prosense-cryoablation-data-and-surge-in-clinical-interest-at-ecio-2026", "source_name": "TipRanks", "published_at": "2026-05-19T13:40:36", "published_display": "19 May 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Medical (ICCM) highlights kidney and breast cryoablation data at ECIO 2026", "summary": "IceCure Medical announced new clinical data from its ProSense\u00ae cryoablation system for kidney and breast tumors, presented at ECIO 2026. The data showed an 89.4% recurrence-free rate in kidney cancer patients with tumors \u22643 cm and 83.9% overall at a 4-year follow-up. Independent ", "url": "https://www.stocktitan.net/sec-filings/ICCM/6-k-ice-cure-medical-ltd-current-report-foreign-issuer-fba5d00a40a1.html", "source_name": "Stock Titan", "published_at": "2026-05-19T12:40:36", "published_display": "19 May 2026 12:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Medical (ICCM) CFO reports 400,000 RSUs equity grant", "summary": "IceCure Medical Ltd.'s CFO, Peleg Meir, has been granted 400,000 restricted share units (RSUs) as part of his equity compensation. The RSUs have a multi-year vesting schedule, with 25% vesting on May 17, 2027, and the remaining 75% vesting in equal quarterly installments of 6.25%", "url": "https://www.stocktitan.net/sec-filings/ICCM/form-3-ice-cure-medical-ltd-initial-statement-of-beneficial-ownership-54cc3b5d36e2.html", "source_name": "Stock Titan", "published_at": "2026-05-18T11:38:58", "published_display": "18 May 2026 11:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxOTlRUVTVIUkMtWmhUSXEzX0RwdlJOUlZVblVNS3RXWV9ZNEoxR0JQNkhVZ2tncW9aMWN1anJNQjduZ1NvTjBaeXkySGpWQ1VrRnRWNHh3Z1FzWGZ6Vlk5RmtGaFZCOXp0RnlhSjJWVmVSY1hJdFlGbWZOOWlHSmQxUkcyZk9Jb3dKUE1JblRQRHVqZlk0dzU2S3cyTlktVDFBeVVxQTNaWWlMcmo2SHdkTF9zRWtxaTZZaDU4Um1kMVVsX2pwdlZhRXZtaElVcmhsTFp0VFExWHpKaXhvdXY4cGNKZw?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure (ICCM) Q1 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/74272ac2-6773-3276-85bb-cef87cd6241d/icecure-%28iccm%29-q1-2026.html", "source_name": "Motley Fool", "published_at": "2026-05-12T16:11:20+00:00", "published_display": "12 May 2026 16:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Reports First Quarter 2026 Financial Results: ProSense\u00ae Sales Increase Substantially in the U.S. and North America", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxQTU0yZW9LSFVKd2FFQ0NSelBWRkE3ck5CSy1QNElCdTJSMFpaWjJhZDI4bkt0NkJqcWVGd2JJQ0RiVXoyYkpKUXJIQkdtODBqZEJXQU81UFpQdWNfdzN0Qm1qUW5wLWtrT3pzNVNhN05kZ3JMUlJWLWp0ZGJ6bEFISzEtdnA4cFRwR1hHQXA2aXdFZ2pYNEQyUzhHbEpKY0c5c3NmSlhxRFdERktaalB1THVlY0dVMkdrbE95b1dESGoxcGhLWVZMSTdZcVBqWldEUEVXR21RV0VJNmFpNkpzOEtyc2tLekVkZGxuNUZ4bDRheWZCVGVTaWRfc2M0c091Z3VaMQ?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Medical Ltd. (ICCM) Reports Q1 Loss, Lags Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPdWJ5cEkzd2NzSUwtRDJfOC1KRGl2Z241MzNTOGwwVU0yUURIUjVBUkdVS0stV2pSenduRDBjeTlTVTVXWXBzellEWG9BN0dOQWdVUm02aWtoT3d1QXlQX3FHeTA5bjBSMi0wdWhUeENNUGpsTFlkdm9fOGVKOHV0bTEtM01PeG5NUXlCZVRMYmtaWkoyT1lpeXphOEpIZw?oc=5", "source_name": "Market source", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[6-K] IceCure Medical Ltd. Current Report (Foreign Issuer) | ICCM SEC Filing - Form 6-K", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxQd0pCMWxDeldiMVgzNEoyTUMtSE5fSHhMdWhPbHNyUHFQdk9fU09idXV2LVJDTUZTM3BGTmI0U0FzNGNYaXk4YnpRNms1WmFRYVVSVXotRWhLOXhEWENpQXZQOUJNYzFWMFhVam5RNjljdHdwTFZaRkJZNURLWVZYc2NuaVdwRnRhQ05oVjFicjhMQjQzLWdnUHgwUzNBUFZicDE2YTYyLTN5N0pnX1pHOG9DOGwwbk0?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Medical (ICCM) prices $4M share sale with concurrent warrants", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPRlkzS3NTYVcyRndZOFZmd01sanROT2ZhZzN5WjlnUWpfaVJlcUE3ZHZfWjduSFZNd3RWb3dwOVBFblI4YXpzbzROTFJLQmIwSmNxUGw4VkJTM3g3RDZ2MjVXa3dMMkl5TlNSSUxETzhiWXZmdTVFVzYzeXNsY1k4NWx5bG5BTmpWbDZHU3JjMFJ1aEwtN2FzVVU1c0txaWdLRGZ1cWhqdDdiQUtPdXlTODQ4OWZyaTg?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-27T07:00:00+00:00", "published_display": "27 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IceCure Announces Pricing of $4.0 Million Registered Direct Offering and Concurrent Private Placement", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxPdWpRN1ZwZ2l4STZXR2JSTVFlWkNiLVhNUDBKSXJhNU1LcWJHNjRORmVMRHc3d2lkWEkwc2tiQmZ2MHlHcXlDeHdDb0d5SkRoazM3TzhvQU0xSlBWa2lGY2xaRWhXdDVremZDdHZ2ZE96WFc1Y3dEdG9BYlJhMlFxRy12R0Y3SjVoTWV4V0R2eVFTY05XM1ROMGkwTFgwWnNxTHN3cWJrcHh6aml3ODlXb2lfMjdKaFp0ZkRTeEdpOHNTME1FNlJwY3VYQUJmeE8wWmdaWGdzd1lMa2E5XzkxSll6enE3UWlkMnhZeQ?oc=5", "source_name": "PR Newswire", "published_at": "2026-03-26T07:00:00+00:00", "published_display": "26 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[EFFECT] IceCure Medical Ltd. SEC Filing", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNVmlUaXNkbmNMcVNlbWxEQm8xRWMzRnNXS2NWUXhuQjRxdW5DcHlEaHEtOHhxemZLX2xpTFVLVGphVHBXY1phTi1SMzBjNlZIT0xBRTVwUm5Kd251WkFsX3IyMkd3R1ZRSVpxRWdMVlVDVzYtWS1UZWhOaTg1dWdWUEtBTVlIYzhWdDEzcUUyY28tTHFEWWxVbjFOZ215ZFRMT0E?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-24T07:00:00+00:00", "published_display": "24 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxQZXhDWktWZlhhSHlxNVZrNWllaDhhWlNXZmhKYlQ4ODRJMHozNTR2TVVKSWVrQV94bzNNU0hfVW5qODRlWW01anFmTG5SYmZoUlJpU09UbkpSemxVbHRGb1F1MGVvZFdqSEVBcUZ5Ti1ZVHlzY3pZYTdCS21RcDJPTnppdWRKVlZjd2ZUeA?oc=5", "source_name": "Market source", "published_at": "2026-03-17T07:00:00+00:00", "published_display": "17 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "U.S. FDA Approves IceCure's Post-Marketing \"ChoICE\" Study for ProSense\u00ae Cryoablation in the Local Treatment of Low-Risk Breast Cancer", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAJBVV95cUxQNkRnRkRMWVJYQjhWTVRRbUdudW1xYlp4S2FsWUpBZWRsVW9ROXVMNVkwcjY3WXd4QUVvOUE5SFNlMnBwU2M5YV9wNWdtX3IwYjcyU204ekkzd3ZxU2ZIdFBiRzlxYnpxV3Z4eXRwSjNxQTFBRUk5WUhMWG1wZ2YwM1E5REhJN3dfQnhLQ3ZWUnNhRUQtTkRRZ2JEQ1ZRZm9XUXd1cXA2S2ozaGd5SjhjbjladWZFMFlZV29Da1RJUFV3YVUtd0QzSkROX2Z3a25EeUZVaGlmS0dyWUhGR1plcm10WW5ZYXpFd0QwVWlhSEgtajVNSlZsRFZadmZrUG9Uay1tNVAxcUZ3MG0tbmFSWHVoR04?oc=5", "source_name": "PR Newswire", "published_at": "2026-03-11T07:00:00+00:00", "published_display": "11 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Lantheus (NASDAQ:LNTH) Vs The Rest Of The Medical Devices & Supplies - Imaging, Diagnostics Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxORnRwNHkwQmJ3Nl9famF1aktWdDdLV2ZfNjFCVm9WSFJrQTRSMURQUEJrMGtZUTFiVEtZWGxyUWwwai04Zk4wZ2pTWXFsLUozTzR2Ykd5UUREenZmSTRWdzJPODNONWFCWUVoVlBuTmtVSnpWQXFOVEVMdWNDLWNfRnRqRWdweElVS2pabQ?oc=5", "source_name": "Market source", "published_at": "2026-03-11T07:00:00+00:00", "published_display": "11 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Winners And Losers Of Q4: Stryker (NYSE:SYK) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxPQVE1TUY2VFFCTHQ0cUpnUWVkOWdGbnRCUnF0VXpQdDYzcGlWVm5ZZHJ1MF85V3NlX0gxbXppZmRXTTFyRk5OclBuQndmMlg0alAzYUp3T2Jaa2VYdzBiZzFYby1SMnlWVlBkSkw4RzRHZjY5bFdqeUpXYk1tOHVQeGtn?oc=5", "source_name": "Market source", "published_at": "2026-03-11T07:00:00+00:00", "published_display": "11 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Specialty Stocks\u2019 Q4 Earnings: Haemonetics (NYSE:HAE) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxQcXUxeEZpRzE0aXJ0RVlrVXZMdF9pSEV3VTROeDNWdjNZZWVDNVhKZU9BRFpIOWlZYzJrU1RZVzFDLUZhRDBjY0pBdVB2YVJUNVZvZEhubmd1OXlobFJaUWxVbUtlVEFwdWNVQnRqMDBHbEFubzBpczN1Zi1mN0xFbC1pTHpqZzA?oc=5", "source_name": "Market source", "published_at": "2026-03-06T08:00:00+00:00", "published_display": "06 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q4 Highlights: Merit Medical Systems (NASDAQ:MMSI)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxQdTQyU1EtSEFYQTdZR0NhU1ZpMVdGNXhiTnlkNm9RWFRka3RfYlZBeklfTFZTRkVaOHBGNi15enNqMGlxVnJad0M5cmp3dUZzYW9Va2tOU19sMnE4V1czcFB4VWRKaVBzYnRtZ0RfVnB5TkloY3U5dW4wQllJMDJaS3BQSVNOMHlVRFQ4aDYtSV9HNTViZXc?oc=5", "source_name": "Market source", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Freezing benign breast tumors shrank them 93% in new IceCure study", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxORkRweVN5cGVFY0V2M0xINDR0b2hpY2pwaWxqTmR3a1REamVMaF9jMEpNM1l5WkRGQXpwNGVmMjJpbWpKQndxcEFiREM4LUVfUEdyMXNfOFBSVmxnM0g1LXB2V3oyMl8wcERiS0lGSnpUMU5nQjJrNkJZY242U2VtXzBnWTJTNmxvZHhlY3FJV2JZWVpuWjZ0Z1FCcEZmRjZBWTdQQzQ4VFJUVEZ2R3FsOXNZbVBvT0lzaWY4?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOb3BiQVNFREdNblk2QS10b1lhRUtfb05vU2VFZHB5V0hJT0R4NmhwQWRrcFVsR3UwMjZleFV6N2FEelpZVzY3YWFxSWE1cWpLaTFrQVU4NktkQUloUkxaV3ZTVkh6b1ZmaDdMN2ViX1BUNE4xUTNUZFNlR0syVGlZSg?oc=5", "source_name": "Market source", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q3 Earnings: Inspire Medical Systems (NYSE:INSP) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgJBVV95cUxOekhIMGs0UXlrdHhudkYzRWhSXzBNazdMLXBSTnd5dEFTZDR3MkdBc1AtNUNrcmp4Z1IxNVBuZVJJejdkdjdwT1Zoc0NudGMxVGNjRGxaUGVrYncxekxMNWV5RGlNNjZWUW9vdzdwaVRtTlMzcFl0MWRZNDlTY0xWWkNteE9fTU9LMm5aX1VuSll2UTNONzRqNnVpYXRvbDVIX1lXaGJMV3JKZFltUTVPNVpUc2Q0MHdYVUUydmZUMVo4dDIzLUxjZk53c1J1bDcxTXJWa0VNZXdJanZfbUVHcmgwamRwaGJyc1pXeGhtZ1dnaTJMN2JCeHlJLUFCZXRaVFhaUHozVi1wRlQ1dkE?oc=5", "source_name": "StockStory", "published_at": "2026-01-28T08:00:00+00:00", "published_display": "28 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "When Will IceCure Medical Ltd (NASDAQ:ICCM) Turn A Profit?", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxNejkwTXhIaUtyUFV6N0FrejdMN1JZTFhxaUtKOTdtTjJka2F3MG9oWVpEMDVjdlpsUmdHemRGVER0dXlJdGM1aE9BSmlHSDRpTGZHUW5pbnpHM3diWVZ1bnJ2SVBaR1EzZzhjaE5HRVdCMm13dDlhbTRuX0V3MndmbEtPNA?oc=5", "source_name": "Market source", "published_at": "2026-01-15T08:00:00+00:00", "published_display": "15 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 91, "total_relevant": 65, "sentiment_summary": {"positive": 19, "negative": 4, "neutral": 42, "score": 57, "total": 65, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 19.05, "count": 34}, {"event": "earnings", "label": "Earnings", "weight": 13.55, "count": 24}, {"event": "macro", "label": "Macro sensitivity", "weight": 1.1, "count": 2}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.1, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 19, "negative_events": 4}, "market_context": {"has_market_context": true, "latest_close": 5.4, "latest_week": "2026-06-19", "one_week_move": 125.9, "four_week_move": -23.4, "twelve_week_move": -52.0, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.846896, "market_dynamics_buy_signal": false, "relative_strength": -78.153704, "fair_value_gap": -79.8, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 38.4371, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+125.9% over one week, -23.4% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 66, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 15}, {"label": "Stock Titan", "count": 12}, {"label": "PR Newswire", "count": 7}, {"label": "GuruFocus", "count": 3}, {"label": "TechStock\u00b2", "count": 2}, {"label": "Benzinga", "count": 2}, {"label": "TradingView", "count": 2}, {"label": "StockStory", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 65}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 34}, {"label": "Earnings", "count": 24}, {"label": "Macro sensitivity", "count": 2}, {"label": "Regulatory and legal", "count": 2}, {"label": "Deals and strategy", "count": 1}, {"label": "Guidance", "count": 1}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "57/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "65", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+125.9% over one week, -23.4% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "This Undervalued Medical-Devices Stock Is Poised for a Rebound"}], "updated_at": "2026-06-22T20:38:23.557807+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}